Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lymph Node Dissection and Chylothorax - Balancing Oncologic Benefit Against Morbidity.

The Annals of thoracic surgery·2026
Same author

Updated Analysis of the Impact of Pulmonary Function Tests on Complications After Lung Resection.

Annals of thoracic surgery short reports·2026
Same author

Staged Hybrid Treatment of a Large Aneurysmal Pulmonary Sequestration With Thoracic Endovascular Aortic Repair Followed by Lobectomy.

Annals of thoracic surgery short reports·2026
Same author

The impact of perioperative outcomes on long-term survival after esophageal cancer resection.

JTCVS open·2026
Same author

Deep-learning based quantitative evaluation of postoperative atelectasis following right upper lobectomy.

NPJ digital medicine·2026
Same author

A Society of Thoracic Surgeons General Thoracic Surgery Database Analysis of the Association Between Lymph Node Dissection and Chylothorax.

The Annals of thoracic surgery·2026

Related Experiment Video

Updated: Jun 27, 2025

Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
05:39

Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia

Published on: May 26, 2023

1.5K

Randomized controlled trials in lung cancer surgery: How are we doing?

Lye-Yeng Wong1, Yanli Li2, Irmina A Elliott1,3

  • 1Department of Cardiothoracic Surgery, Stanford University Medical Center, Stanford, Calif.

JTCVS Open
|May 1, 2024
PubMed
Summary

Conducting randomized control trials in thoracic surgical oncology is challenging. Most trials focus on perioperative strategies, and a significant number face long completion times, suggesting a need for careful planning.

Keywords:
lung cancerrandomized controlled trialsthoracic surgical oncology

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.7K

Related Experiment Videos

Last Updated: Jun 27, 2025

Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
05:39

Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia

Published on: May 26, 2023

1.5K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.7K

Area of Science:

  • Thoracic Surgical Oncology
  • Clinical Trial Design
  • Evidence-Based Medicine

Background:

  • Randomized control trials (RCTs) are the gold standard for medical evidence.
  • Implementing RCTs in thoracic surgical oncology presents unique scalability and practicality challenges.
  • The success rate of completing these trials as planned is not well understood.

Purpose of the Study:

  • To identify the types of RCTs conducted in thoracic surgical oncology.
  • To determine the completion rates of these RCTs.
  • To understand the characteristics and timelines of completed thoracic surgical oncology RCTs.

Main Methods:

  • A systematic search of the ClinicalTrials.gov database was performed in April 2023.
  • The search focused on RCTs involving lung cancer patients undergoing surgical treatment.
  • Data on trial design, completion status, and timelines were extracted and analyzed.

Main Results:

  • 68 eligible RCTs were identified, with 48.5% focusing on perioperative or intraoperative strategies.
  • A notable increase in RCTs occurred after 2016.
  • Only 31% of RCTs were completed, with an average accrual time of 4.4 years and outcome collection taking 5.82 years.

Conclusions:

  • The findings highlight significant challenges in completing RCTs in thoracic surgical oncology.
  • Given the resource-intensive nature of RCTs, future proposals require rigorous scrutiny for feasibility.
  • Further research is needed to identify factors contributing to RCT success or failure in this field.